fda tirzepatide approval 🚨 Generic Versions of Mounjaro & Zepbound Move Closer as Reviews First Applications The US Food and Drug Administration (FDA) is reviewing the first applications for generic versions of Eli Lilly's Breakthrough in Weight Management: Zepbound's

Enhanced Rejuvenation Strategies To maximize the power of peptides, we often combine them with other advanced clinical treatments

A Swedish cohort study examined the impact of multiple GLP-1RAs on the incidence of DR in 2,390 diabetic patients

Do not use Saxenda if: you or any of your family have ever had MTC or if you have MEN 2 you have had a serious allergic reaction to liraglutide or any of the ingredients in Saxenda

Featured Products Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, mimics the activity of mammalian incretin hormone glucagon-like peptide 1 (GLP-1), and thus, promotes insulin secretion and functions in the control of glucose [1]